SRC and colorectal carcinoma: This hypothesis will require formal demonstration, but it is in line with the data that we obtained in CRC cell lines and primary tumors (Fig. 6) and with the notion that, both in pancreatic cancer and CRC, Src activation cooperates with KRASMUT, correlating with tumor dissemination and poor prognosis [51, 52].